Identification of the transcriptionally activated targets of receptor tyrosine kinases is critical to understanding biologic programs directing both normal and neoplastic growth. To elucidate these molecular processes, we identified genes induced by a potent mesenchymal mitogen, platelet-derived growth factor (PDGF). Using differential display reverse transcription-polymerase chain reaction technology, we isolated a novel growth factor-induced cDNA, San5. San5 transcript induction occurred within 60 min in NIH 3T3 fibroblasts and proceeded in the presence of cycloheximide. Maximal induction of the San5 transcript occurred between 8 and 16 h, concurrent with passage of fibroblasts through G 1 . San5 message was potently induced by PDGF AA and BB and acidic and basic fibroblast growth factors, all strong activators of fibroblast proliferation, but not by epidermal growth factor and interleukin-4. In a murine hematopoietic progenitor cell line, San5 transcript induction strictly correlated with [ 3 H]thymidine uptake. Isolation and sequencing of the murine San5 cDNA revealed amino acid sequence homology to yeast Nop5p, a nucleolar protein required for pre-rRNA processing and ribosome assembly. Strikingly, SAN5 was able to rescue a nop5 null mutant, implicating SAN5 in the process of ribosome biogenesis. Consistent with this result, SAN5 was localized to the nucleolus in both yeast and mouse. Thus, San5 may provide a link between growth factor receptor activation and the cellular translational machinery.
Early investigations have sought to explain the molecular mechanisms by which growth factor binding to receptor elicits functional responses via the induction of specific gene transcripts (1) (2) (3) . These studies of the rapid signaling from cellsurface receptors to nuclear transcriptional activation in the absence of protein synthesis led to the identification of early response genes (4) that have been generally associated with the passage of quiescent cells into the G 1 phase of the cell cycle (5, 6) . Subsequent studies have clearly shown that early response genes mediate many of the cellular responses of growth factors (1) . Indeed, the many types of early response genes such as proto-oncogenes, transcription factors, chemokines, cytokines, and structural proteins suggest that the combinatory use thereof may integrate growth, differentiation, and apoptotic networks (1, 3, 7) .
Cellular processes directed toward achieving tissue homeostasis, including growth, differentiation, development, and wound healing, are mediated in part by growth factors (8, 9) such as the platelet-derived growth factors (PDGFs) 1 and fibroblast growth factors (FGFs). PDGF is the major serum proliferative and chemotactic factor for cells of mesenchymal origin (10 -12) . In addition to release from platelets, PDGF is secreted in a paracrine fashion from epithelial cells and activated macrophages (13) . Accumulating evidence suggests that abnormal PDGF expression, either paracrine or autocrine, contributes directly or indirectly to a number of pathological states, including neoplasia and arteriosclerosis as well as lung, kidney, and bone marrow fibrosis (10, (13) (14) (15) . The FGFs target multiple cell types and are thought to have a role in vascular disease, tumorigenesis, and regulation of bone growth (16 -18) . Recently, several human genetic bone disorders have been attributed to activating mutations in three of the four known FGF receptors (19) .
Interaction of a growth factor such as PDGF or FGF with its unique receptor(s) leads to activation of the receptor tyrosine kinase and autophosphorylation (11, 12) . Many proximal downstream signal transduction molecules (reviewed in Ref. 20) , including phosphatidylinositol 3-kinase, Src-like kinases, Ras, STATs, and nuclear factor B, have been implicated as effectors of growth factor signaling pathways. Within the nucleus, receptor signal transduction pathways lead to the transcriptional activation of early response genes such as egr-1, fos, jun, and JE/MCP-1 (reviewed in Refs. 1, 4, and 21). Clearly, understanding growth factor transcriptional activation and the myriad processes related to cellular growth and differentiation will be critical to ultimately regulating cellular behavior. Early response genes may also present therapeutic targets since their activation is directly dependent on signaling molecules present during growth factor activation. Here, we exploited differential display reverse transcription technology to isolate a delayed early response gene induced by multiple growth factors that complements a lethal defect in yeast ribosome biogenesis.
EXPERIMENTAL PROCEDURES
Materials-Anti-SAN5 peptide serum used for immunoprecipitation or immunoblot analysis was raised against amino acids 322-338. PDGF AA, PDGF BB, acidic and basic FGFs, epidermal growth factor, IL-1, IL-2, IL-3, IL-4, IL-13, and GM-CSF (used at 100 ng/ml in San5 induction experiments) were obtained from Peprotech (Rocky Hill, NJ). Anti-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Lab. Kip1 and anti-p34 Cdc2 antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). AlexaFluor TM 568 goat anti-rabbit IgG was obtained from Molecular Probes, Inc. (Eugene, Oregon).
Differential Display RT-PCR-Differential display RT-PCR was performed essentially as described (22) . Briefly, 2 g of total cellular RNA isolated from PDGF BB-treated (100 ng/ml) and untreated NIH 3T3 fibroblasts was reverse-transcribed using random primers. Amplicons were separated on 6% polyacrylamide gels, fragment-isolated, and TAcloned into pCRII (Invitrogen, Carlsbad, CA). After bacterial transformation, cDNA was prepared from individual colonies, and rescued inserts were tested by Northern hybridization as well as sequenced by the dideoxy chain termination method using T7 polymerase (U. S. Biochemical Corp.).
cDNA Cloning and NIH 3T3 Cells-A cDNA library was constructed using oligo(dT)-primed murine NIH 3T3 fibroblast cDNAs packaged into pCEV27 (23) . For library screening, the bacterial strain Y1088 was infected with phage (2 ϫ 10 4 plaques/150-mm plate). Nitrocellulose filters were hybridized with the 350-base pair 32 P-labeled San5 amplicon in Hybrisol-I (50% formamide, 10% dextran sulfate, 1% SDS, 6ϫ SSC, and blocking agents; Oncor, Gaithersburg, MD) at 42°C for 20 h, washed under low stringency conditions (3ϫ SSC and 0.1% SDS; once at 25°C for 30 min and three times at 40°C for 30 min), and exposed to Kodak XAR film. The cDNA inserts from plaque-purified clones were sequenced as described above.
Northern Blot Analysis-NIH 3T3 cells were maintained in Dulbecco's modified Eagle's medium containing 10% calf serum throughout this study unless otherwise indicated (24) . NIH 3T3 cells were transfected as described (25) . For Northern blot analysis, total RNA was prepared from NIH 3T3 fibroblasts in the presence of Trizol (Life Technologies, Inc.), extracted with chloroform, and recovered by precipitation with isopropyl alcohol. Typically, 20 g of total RNA was resolved by electrophoresis on 1.0% formaldehyde-agarose gels and transferred to Nytran nylon membranes. After UV cross-linking of the RNA to the membrane, filters were prehybridized for 4 h at 42°C in Hybrisol-I and then hybridized for 20 h in the same solution containing 32 P-labeled San5 (1.6 kilobase pair BamHI fragment of the entire murine San5 cDNA coding region). Filters were washed twice (30 min each) at room temperature with 2ϫ SSC and 0.1% SDS and twice at 50°C with 0.1ϫ SSC and 0.1% SDS and exposed to Kodak XAR film.
Western Blot Detection of SAN5-Whole cell lysates were prepared as described previously (23) , and total protein was determined by the method of Bradford (42) . Nuclear and cytoplasmic extracts were prepared (26) . Equivalent amounts of lysate were suspended in SDSpolyacrylamide gel electrophoresis (PAGE) sample buffer containing 100 mM dithiothreitol and fractionated on 10% SDS-polyacrylamide gels.
After electrophoretic transfer to Immobilon-P membranes, filters were blocked in PBST (phosphate-buffered saline and 0.05% Tween 20) with 5% nonfat milk as described previously (24) . Membranes were then incubated with anti-SAN5, preimmune, or control serum (1:1000) overnight in PBST and washed four times with PBST. Bound antibody was detected by incubation with anti-rabbit antibody (1:10,000) conjugated to horseradish peroxidase (Amersham Pharmacia Biotech) for 30 min and subsequently washing four times with PBST. Enhanced chemiluminescence (Amersham Pharmacia Biotech) was performed according to the manufacturer's protocol. Mitogenic Assay-[ 3 H]Thymidine incorporation into 32D cells (27) and NIH 3T3 cells was performed as described previously (28) with the following modifications. 32D cells (2 ϫ 10 5 cells/ml) were passaged in RPMI 1640 medium with 15% fetal bovine serum containing 5% WEHI. 32D cells were washed and resuspended in RPMI 1640 medium for 2 h, followed by cytokine or growth factor addition. After 15 h of stimulation, cells were harvested for RNA preparation or incubated with [ 3 H]thymidine (2 Ci/ml) for 5 h, washed, and harvested onto glass filters with an automatic harvester (Skatron). [ 3 H]Thymidine incorporation was measured using a Beckman 5500 scintillation counter. 32D cells treated with fetal bovine serum alone incorporated Ͻ0.1% of the counts incorporated in the presence of IL-3.
Expression of Epitope-tagged SAN5 in Yeast-The San5 coding region was amplified by PCR using the following primers: 5Ј-ATTAAG-GATCCCTCATCATGTTGGTCCTGTTTGAAACG-3Ј and 5Ј-ATTAAG-GATCCTCACTTGTCGTCGTCGTCCTTGTAATCCTCTGGACTAGGA-ACTGCTGTGCT-3Ј. This resulted in the introduction of the FLAG epitope tag at the C terminus of SAN5. To avoid amplification problems associated with the repetitive sequence at the 3Ј-end of the San5 coding region (see Fig. 6 ), the lower primer was designed to replace amino acids 488 -500 (KKKKKKKKKDAED*) with the FLAG epitope tag sequence (DYKDDDDK*). The PCR product was cloned downstream of the GAL1 promoter in pJWY1 to create pLA1012. pJWY1 was constructed by subcloning the GAL1,10 promoter region (on a BamHI-NotI fragment) from pRD53 into the BamHI and NotI sites of pRS313 (36) . pLA1012 (GAL1-San5-FLAG, HIS3) was transformed into YPW45, which has been previously described (36) and which contains a disruption of nop5 (nop5::TRP1) and a complementing plasmid, pPW80 (NOP5, URA3). The resulting transformant, containing plasmids pLA1012 and pPW80, was grown on synthetic galactose medium without histidine but with uracil to permit spontaneous loss of pPW80. Subsequently, cells were transferred to synthetic medium containing 1 mg/ml 5-fluoroorotic acid to kill cells that had not lost pPW80 and remained URA3
ϩ . In this manner, plasmid shuffling was used to replace pPW80 with pLA1012 in YPW45 to create strain YJPA30. For control purposes, pPW82 (GAL1-NOP5, HIS3) was shuffled into YPW45 in parallel to create strain YPW49.
Yeast strains were grown in rich medium (YPD (1% yeast extract, 2% peptone, 2% glucose) or YPG (1% yeast extract, 2% peptone, 2% galactose)) or synthetic medium (SD or SG) containing either glucose (D) or galactose (G) as well as required nutritional supplements (36) . For the growth curve, cultures were maintained at A 600 Ͻ 0.5 by dilution with medium. All strains were derivatives of strain W303a.
Western blot detection of SAN5-FLAG in whole yeast cell lysates was done as described (36) using anti-FLAG monoclonal antibody M2 (Sigma) or anti-SAN5 peptide serum. The control strain YPW48 has been previously described (36) and is identical to YJPA30 except that it contains plasmid pPW81 (GAL1-NOP5, LEU2) instead of pLA1012 (GAL1-San5-FLAG, HIS3).
Immunofluorescent Localization of SAN5-Immunofluorescence localization of SAN5-FLAG in yeast was done as described (36) For SAN5 localization in NIH 3T3 cells, cells were plated on fibronectin-coated borosilicate slides with chambered coverglass (Lab-Tek). Cells were fixed for 30 min at room temperature in 4% paraformaldehyde. After washing three times with PFN buffer (phosphate-buffered saline, 10% fetal calf serum, and 0.02% NaN 3 ), cells were permeabilized in 0.1% Triton X-100 for 4 min at room temperature, washed again with PFN buffer, and then incubated with either anti-SAN5 IgG or nonimmune rabbit IgG at 6.8 g/ml in PFN buffer for 1 h at room temperature. Cells were washed three times with PFN buffer and then incubated with AlexaFluor TM 568 goat anti-rabbit antibody at 1:5000 for 1 h at room temperature. Image data were collected on a Zeiss Axiophot microscope equipped with a Spot CCD camera and captured using Adobe Photoshop.
RESULTS

Identification of a Novel Delayed Early Response Gene-
Serum growth factors maintain tissue homeostasis by mediating proliferation and differentiation of responsive cells. Characterization of changes in gene expression that occur in response to a given growth factor is an essential step in understanding growth factor function. Using PDGF-responsive NIH 3T3 fibroblasts, we used differential display RT-PCR analysis to identify novel transcripts induced or repressed in the presence of PDGF. Total RNA was isolated from quiescent NIH 3T3 fibroblasts and from cells treated with PDGF BB for 2 h. RT-PCR analysis revealed that several amplicons were induced in PDGF treated, but not untreated, fibroblasts. These amplicons were isolated, TA-cloned into plasmid pCRII, and sequenced to identify unique amplicons. After Northern blot analysis, one amplicon was found to strongly hybridize to a single PDGF-induced 2.8-kilobase transcript. As shown in Fig.  1A , this transcript was expressed at low levels in quiescent fibroblasts, but by 2 h following PDGF addition, its levels were induced ϳ3.5-fold. This amplicon was used to screen an NIH 3T3-CEV27 cDNA library. The isolated cDNA, determined to be a unique sis-activated nucleotide sequence after DNA sequence analysis, was designated San5.
To investigate the protein nature of the San5 gene product, we raised anti-SAN5 peptide serum based on the predicted San5 amino acid sequence. NIH 3T3 whole cell lysates were prepared, resolved by SDS-PAGE, and immunoblotted with anti-SAN5 serum. As shown in Fig. 1B , Western blot analysis of NIH 3T3 lysates revealed a band of ϳ66 kDa detected by the anti-SAN5 serum, but not by preimmune or control serum. Incubation of the anti-SAN5 serum with the peptide used for antiserum generation also blocked immunodetection (Fig. 1B) . This result was confirmed by a second unique anti-SAN5 peptide serum that also recognized a 66-kDa species (data not shown). In further experiments, in vitro translation of the San5 cDNA resulted in peptides of 66 and 60 kDa that were specific to the SAN5 translation reaction and immunoprecipitable with anti-SAN5 serum (data not shown). Taken together, these data suggest that the San5 cDNA encodes a 66-kDa gene product.
San5 Induction Kinetics and Effects of Cycloheximide-The relatively rapid induction of San5 led us to investigate whether it might be a primary response gene. Studies of the kinetics of San5 transcript expression showed that after stimulation of NIH 3T3 fibroblasts with PDGF BB, the San5 message was first detected within ϳ1 h ( Fig. 2A) . In contrast to the immediate early response genes JE and c-fos, whose transcripts decayed after 2 h of exposure to growth factor, San5 expression continued to increase 4 -5-fold over basal expression levels after as long as 4 h (Fig. 2A) .
Besides rapid induction, another characteristic of primary response genes is transcriptional activation independent of de novo protein synthesis. To determine whether induction of San5 required protein synthesis, NIH 3T3 fibroblasts were pretreated with 100 M cycloheximide for 30 min, followed by PDGF BB treatment for the indicated time periods. As shown in Fig. 2A , San5 induction after both cycloheximide and PDGF BB treatment was not inhibited. Consistent with previous reports (1) , induction of the immediate early genes JE and c-fos was not inhibited, and superinduction was observed ( Fig. 2A) . In contrast to the greatly enhanced JE and c-fos transcription in the presence of both cycloheximide and PDGF BB, only a modest increase (ϳ2-fold) in San5 message levels was observed compared with PDGF treatment alone ( Fig. 2A) . Thus, San5 exhibits characteristics of an early response gene.
San5 Transcript Induction during G 0 and Persistence throughout G 1 -Activation of early response genes is often associated with passage of quiescent cells (from G 0 ) to G 1 , followed by progression through the cell cycle and, ultimately, cell division. To determine the timing of San5 induction relative to the cell cycle, RNA was isolated from NIH 3T3 cells starved overnight and then treated with PDGF BB for periods ranging from 1 to 24 h. Northern blot analysis revealed that San5 message levels peaked around 8 h and did not decline until later in the cell cycle (Fig. 2B) . By 24 h after addition of PDGF, message levels had decayed to those seen at 2 h postinduction. Previous work in NIH 3T3 fibroblasts has established that G 1 occurs between 6 and 15 h (29). S phase, as measured by [ 3 H]thymidine incorporation, began at ϳ15 h (data not shown). San5 transcript expression thus increased and was sustained through G 1 , and diminished to a lesser steady-state level as the cell entered S phase.
To determine if SAN5 protein induction also correlated with passage of cells into G 1, SAN5 protein levels were analyzed by Western blotting with anti-SAN5 serum. Quiescent NIH 3T3 cells were treated with PDGF BB for 4 -24 h, and lysates were prepared. As shown in Fig. 2C , p66SAN5 increased noticeably by 6 -8 h after PDGF induction, coincident with the onset of G 1 , as measured by loss of p27
Kip1 , a known G 0 marker. SAN5 protein levels increased 2.5-3-fold prior to the appearance of Cdc2, a G 2 /M marker, and plateaued between 12 and 18 h. The delay in SAN5 protein accumulation relative to its mRNA is consistent with a translational control mechanism commonly observed during ribosomal protein synthesis (30) . The San5 gene product was expressed upon entrance into the cell cycle, and its expression was sustained through G 2 , suggesting that SAN5 may be involved in events preparative to cell division.
Multiple Growth Factor Induction of San5 and Correlation A, NIH 3T3 fibroblasts were treated with PDGF BB for the indicated time periods; total RNA was prepared; and Northern blot analysis was performed as described under "Experimental Procedures." In some instances, cells were pretreated for 30 min with 100 M cycloheximide (ϩCHX) prior to growth factor stimulation. Filters were hybridized with 32 P-labeled cDNA probes to San5, JE, c-fos, or 18 S ribosomal RNA and subjected to autoradiography. B, shown is San5 induction during the NIH 3T3 cell cycle. After PDGF BB treatment for the indicated time periods, total RNA was harvested, and Northern blot analysis was performed with 32 P-labeled San5 or 18 S rRNA cDNA probes. C, NIH 3T3 fibroblasts were treated with PDGF BB for the indicated times; whole cell lysates were prepared; and equivalent amounts (100 g) were resuspended in 2ϫ SDS sample buffer and 100 mM dithiothreitol. Proteins were resolved by SDS-PAGE; transferred to an Immobilon-P membrane; and immunoblotted with anti-SAN5, anti-p27 Kip1 , or anti-Cdc2 antiserum. Bound primary antibody was detected as described under "Experimental Procedures."
with Factor-induced [ 3 H]Thymidine Uptake-One function of growth factors is to induce quiescent cells to enter G 1 and subsequently divide. As the onset of San5 induction spanned the G 0 to G 1 transition, we asked whether the gene was inducible by growth factors other than PDGF-BB that also elicit fibroblast proliferation. NIH 3T3 fibroblasts were treated for 2 h with PDGF BB, PDGF AA, acidic or basic FGF, epidermal growth factor, or IL-4. Total RNA was isolated, and Northern blot analysis was performed. As shown in Fig. 3A , San5 message levels were increased in the presence of PDGF BB, PDGF AA, and acidic and basic FGFs, which are strong fibroblast mitogens. At 2 h, the FGFs elevated San5 transcript levels ϳ3.5-4-fold, as determined by NIH Image 1.6 analysis, whereas PDGF BB induced the message ϳ3-fold (Fig. 3B) . Epidermal growth factor and IL-4, which are weak fibroblast mitogens, had no effect on San5 message levels. In epitheliumderived Balb/MK cells, hepatocyte and keratinocyte growth factors, but not IL-4, induced San5 message (data not shown).
PDGF and the FGFs are known to be potent fibroblast mitogens (31, 32) . Similarly, hepatocyte and keratinocyte growth factors induce growth and proliferation of epithelial cells (33, 34) . To further test our hypothesis that increases in San5 message levels correlated with proliferation, we exploited 32D cells, a hematopoietic progenitor cell line whose growth is dependent on the presence of IL-3 or GM-CSF (27, 35) . 32D cells were treated with IL-1, IL-2, IL-3, IL-4, IL-13, and GM-CSF, and Northern blot analysis of the San5 transcript was performed. As shown in Fig. 4A , San5 message levels were elevated only in the presence of IL-3 and GM-CSF (an ϳ5-fold increase in message levels). Treatment with other cytokines did not have this effect on San5 message. We next measured 32D cell proliferation by [ 3 H]thymidine incorporation after cytokine treatment. Again, only IL-3 or GM-CSF strongly stimulated [ 3 H]thymidine uptake (Fig. 4B) . We conclude that San5 induction in 32D cells strongly correlates with [ 3 H]thymidine uptake and may be a useful indicator of proliferation. The ability of several growth factors to induce San5 expression in different cell types, as well as the correlation between potency of induction and the ability of a given growth factor to promote proliferation, suggests that San5 may participate in the passage of cells from a resting to an actively dividing state.
Subcellular Location of SAN5 and Effects on NIH 3T3
Proliferation-To determine the subcellular location of SAN5, we first prepared nuclear and cytoplasmic extracts from NIH 3T3 cells transfected with SAN5 (pCEV27-SAN5) or empty vector (pCEV27). Western blot analysis identified a 66-kDa band representing endogenous SAN5 and a minor faster migrating species (ϳ60 kDa), both located predominantly in the nuclear fraction (Fig. 5A) . Reprobing of the blots with antibodies to known nuclear (p53) and cytoplasmic (glyceraldehyde-3-phosphate dehydrogenase) proteins confirmed correct partitioning of the lysates. The p60 species was greatly increased in extracts from cells transfected with pCEV27-SAN5 and identifies ectopically expressed SAN5. Whether the smaller size of the protein is due to internal initiation, proteolysis, or post-translational modification(s) is currently under investigation.
To more directly observe the intracellular distribution of SAN5 protein in mammalian cells, NIH 3T3 cells were incubated with anti-SAN5 IgG or control IgG and visualized with AlexaFluor TM 568 goat anti-rabbit IgG. SAN5 protein was detected predominantly in the nucleus, in a punctate pattern typical of mammalian nucleolar staining (Fig. 5B) . Control IgG did not result in any nucleolar staining. Taken together with our Western blot analysis of nuclear preparations, these results suggest that SAN5 protein is located predominantly in the nucleolus.
We have shown that SAN5 expression is elevated in cells undergoing proliferation. To determine if increased amounts of SAN5 can affect fibroblast proliferation, [ 3 H]thymidine uptake was compared in untransfected NIH 3T3 cells, cells transfected with pCEV27-SAN5, and cells transfected with pCEV27. All cells were starved overnight and serum-treated for 15 h, and A, NIH 3T3 fibroblasts were treated with the indicated growth factor or cytokine for 0, 0.5, 1.0, 1.5, or 2 h as described under "Experimental Procedures." Total RNA was prepared, and Northern blot analysis was performed. Filters were hybridized with 32 P-labeled cDNA probes to San5 or 18 S ribosomal RNA and subjected to autoradiography. B, San5 transcript levels from A were quantitated with NIH Image 1.6 over the time course of induction. aFGF and bFGF, acidic and basic FGFs, respectively; EGF, epidermal growth factor; mIL-4, murine IL-4.
FIG. 4. Comparison of San5 transcript induction with mitogenesis.
A, 32D hematopoietic progenitor cells were treated with the indicated growth factor or cytokine for 15 h as described under "Experimental Procedures." Total RNA was prepared, and equivalent amounts were subjected to Northern blot analysis. Filters were hybridized with a 32 P-labeled cDNA probe to San5 and subjected to autoradiography. B, shown is growth factor-or cytokine-induced mitogenesis in 32D cells. 32D cells were treated with the indicated factor as described under "Experimental Procedures." Each bar represents the average fold induction Ϯ S.E. of three determinations. Fold induction was calculated by dividing [ 3 H]thymidine uptake in the presence of factor by uptake in the absence of factor. mSAN5, murine San5. not display growth in soft agar or focus-forming activity. 2 Therefore, although SAN5 expression is associated with cellular proliferation, increased expression of SAN5 did not significantly alter fibroblast proliferation.
Isolation and Cloning of San5 cDNA-To more thoroughly characterize the San5 gene and its encoded product, the San5 cDNA was isolated from an oligo(dT)-primed cDNA library after screening with the 350-base pair San5 probe generated from differential display RT-PCR. The San5 open reading frame encompassed 1500 base pairs, beginning with an initiation codon at position 162 and ending with a termination codon at position 1662 (Fig. 6A) . 5Ј-and 3Ј-untranslated regions of 161 and 230 nucleotides flanked the open reading frame, with a potential polyadenylation signal (AATAAA) at position 1829.
Analysis of the deduced amino acid sequence of San5 using the Motifs program predicted that SAN5 has several phosphorylation consensus sites for tyrosine kinase, casein kinase II, and protein kinase C. The carboxyl-terminal region of SAN5 is lysine-rich and contains two Lys-Lys-(Asp/Glu) repeats, a motif found in microtubule-associated proteins and thought to be involved in cytoskeletal interaction.
Comparison of SAN5 amino acid sequence (Fig. 6B ) with known sequences from the BLAST data base showed that SAN5 shares 57% amino acid homology with the yeast nucleolar protein Nop5p, which has been demonstrated to have a role in yeast ribosome biogenesis (36) . The similarity of SAN5 to proteins involved in ribosome biogenesis and its expression during G 1 further suggest participation of SAN5 in these processes.
San5 Complements a Lethal Defect in Yeast Ribosome
Biogenesis-Since murine SAN5 shares some amino acid sequence homology with yeast Nop5p/Nop58p, we investigated whether San5 might complement yeast containing a disruption of NOP5, which is essential for growth (36, 37) . For expression in yeast, san5 was amplified by PCR using primers designed to introduce a FLAG epitope tag at the C terminus of SAN5 (see "Experimental Procedures"). San5-FLAG was cloned downstream of the inducible/repressible GAL1 promoter in a low copy number centromeric plasmid to yield pLA1012 (GAL1-San5, HIS3). To test if San5-FLAG could functionally replace NOP5, strain YPW45 was transformed with pLA1012. YPW45 contains a nop5::TRP1 disruption and complementing plasmid pPW80 (NOP5, URA3) (36) . The resulting transformant was grown on medium containing uracil to permit spontaneous loss of pPW80 and containing galactose to induce expression of SAN5-FLAG (see "Experimental Procedures"). After transfer to synthetic medium containing the drug 5-fluoroorotic acid, which kills cells that retain pPW80, colonies were observed in the SAN5-FLAG-complemented strain, but were small in size compared with colonies from a control strain (Fig. 7A) . This indicates that San5-FLAG can functionally replace SAN5, Nop5p, but that the restoration of function is not complete. The San5-FLAG-complemented strain YJPA30 grows more slowly on rich medium than YPW48 (GAL1-NOP5) (Fig. 7, B and C) and has a doubling time of ϳ11 h at 25°C, which is ϳ3-fold slower than the parental strain W303 grown under the same conditions (Fig. 7B) . To confirm that the viability of YJPA30 was due to San5, which is expressed on SG medium and repressed on SD medium, we examined the growth of YJPA30 on SG and SD media. After 3 days on SD medium, which normally supports faster growth than SG medium, no growth of YJPA30 was observed (Fig. 7C) .
Considering that Nop5p and SAN5 are significantly different in sequence (46.4% identical by Lipman-Pearson alignment over 502 residues; Nop5p is 511 residues in length), it is not surprising that complementation of the nop5 null allele with murine San5-FLAG does not fully restore growth. Because slow growing yeast mutant strains often exhibit temperature sensitivity, we examined the growth of YJPA30 at 37°C. 
FIG. 5. Subcellular localization and mitogenic activity of SAN5 in NIH 3T3 cells.
A, nuclear and cytoplasmic preparations from NIH 3T3 cells transfected with pCEV27 or pCEV27-SAN5 were prepared, and equivalent amounts (100 g) were resuspended in 2ϫ SDS sample buffer and 100 mM dithiothreitol. Proteins were resolved by SDS-PAGE; transferred to an Immobilon-P membrane; and immunoblotted with anti-SAN5, anti-p53, or anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antiserum. Bound primary antibody was detected as described under "Experimental Procedures." B, NIH 3T3 cells were fixed in 4% paraformaldehyde. Cells were incubated with either anti-SAN5 IgG or control IgG. Bound primary antibody was detected using AlexaFluor TM goat anti-rabbit fluorescent antibody. C, serum-induced YJPA30 did not grow at 37°C on rich medium (Fig. 7C) or on minimal medium (data not shown). Further studies showed that YJPA30 formed colonies similar in size to colonies produced by YPW48 at 33°C, but formed only very small colonies at 35°C (data not shown).
To directly verify that SAN5-FLAG was expressed in YJPA30, Western blotting was done on whole cell protein lysates from YJPA30 (Fig. 7D) . Antibodies against the FLAG tag and SAN5 itself specifically detected a 60-kDa band on SDS gels that is not present in strain YPW48. The size of the 60-kDa band is in good agreement with the predicted size of the SAN5-FLAG protein. The intensity of the 60-kDa band suggests that heterologous expression of SAN5-FLAG in yeast is reasonably well tolerated and does not lead to rapid degradation of SAN5-FLAG.
SAN5 Is Localized to the Nucleolus in Yeast-To determine the intracellular distribution of SAN5-FLAG, indirect immunofluorescent labeling of strain YJPA30 was performed (Fig. 8) . YJPA30 was grown on rich medium containing galactose to induce expression of SAN5-FLAG or on rich medium containing glucose to deplete SAN5-FLAG in vivo. Staining with anti-FLAG antibody revealed a pattern that substantially overlapped with the distribution of the nucleolar protein Nop1p (Fig. 8, a and b) . In addition, anti-FLAG antibody staining produced a crescent-shaped pattern adjacent to, or partially overlapping with, chromatin, which was visualized with 4,6-diamidino-2-phenylindole (Fig. 8c) . This pattern is typical of nucleolar staining in yeast. The nucleolus is associated with the nuclear envelope in yeast and forms a "cap" or "crescent"-shaped region within the nucleus. During mitosis in yeast, the nuclear envelope does not break down, and the nucleolus becomes elongated as it is partitioned between mother and daughter cells. Shifting YJPA30 to glucose-containing medium for 6 h dramatically reduced the level of anti-FLAG antibody staining (Fig. 8e) . Anti-Nop5p mAb, which does not cross-react with SAN5 protein in Western blots, failed to detect Nop5p in YJPA30 (Fig. 8i) . However, anti-Nop5p mAb detected Nop5p in YPW49 (GAL1-NOP5) (Fig. 8m) , which substantiates the absence of Nop5p from YJPA30. It is worth noting that expression of SAN5-FLAG in YJPA30 affected the distribution of the nucleolar protein Nop1p to a limited degree, resulting in a Nop1p staining pattern (Fig. 8b ) that was slightly more heterogeneous than is normally observed in wild-type cells (data not shown).
DISCUSSION
In this report, we exploited differential display reverse transcription technology to isolate a novel murine gene, San5, that was induced by multiple growth factors coincident with cell cycle progression. Induction of the San5 transcript was rapid, did not require de novo protein synthesis, and initially paralleled early response gene transcriptional kinetics. Further experiments demonstrated that San5 message reached maximal sustained induction with the kinetics of a delayed early response gene. The increase in the amount of San5 transcript strongly correlated with the ability of a given factor to induce proliferation. Molecular cloning and cDNA sequence analysis revealed that San5 shows some sequence homology to yeast NOP5, whose gene product was recently implicated in the early events of ribosome biogenesis. Ectopically expressed SAN5-FLAG was localized to the yeast nucleolus and rescued the growth of a yeast mutant deficient in NOP5. All of these data suggest that we have cloned a multiple growth factor-inducible gene similar to yeast NOP5 that may participate in fundamental growth processes.
Early response gene expression is often observed as cells transit from a quiescent to an actively growing state. As metabolically active cells require increased rates of protein synthesis, it is likely that a gene involved in ribosome biogenesis would be induced early in this process (30) . The increase in San5 message levels observed upon treatment with growth factors is most likely due to up-regulation of transcription, as this increase is not seen in the presence of the transcription inhibitor actinomycin D. 3 We have classified San5 as an early response gene based on its relatively rapid induction and on its transcription in the absence of protein synthesis, a hallmark of immediate early genes. In contrast to the immediate early genes JE and c-fos, whose expression is repressed after 2-4 h in the presence of growth factor (1-3), San5 synthesis did not appear to be tightly repressed by continuous growth factor exposure. Its persistent robust expression later in the cell cycle may indicate functional activity throughout this period.
In mammalian cell culture models, growth factors have specific effects on their target cells, such as the induction of differentiation or proliferation. We closely examined the effect of various growth factors on San5 expression in fibroblasts and in a hematopoietic progenitor cell line. In both cases, San5 message was elevated to the greatest extent in response to growth factors or cytokines known to induce cell type-specific proliferation. In fibroblasts, treatment with PDGF AA, PDGF BB, and acidic and basic FGFs, all potent inducers of fibroblast proliferation (10), resulted in increased San5 transcript levels, whereas weak inducers of proliferation failed to elevate San5 message levels significantly. Likewise, treatment of 32D cells with the cytokines IL-3 and GM-CSF, upon which these cells depend for growth (27, 28) , resulted in high [ 3 H]thymidine uptake and a coincident increase in San5 transcript expression. Therefore, regulation of San5 message levels may be one way in which growth factors and cytokines exert their effects on cells.
Given the similarity of SAN5 to yeast Nop5p and the ability of San5 to rescue a nop5 null mutant, San5 may prove to have a similar function in mammalian cells. In yeast, NOP5 is required for synthesis of the 40 S ribosomal subunit and is involved in pre-rRNA processing, specifically cleavage of the 35 S-labeled precursor rRNA at sites A 0 and A 2 . Nop5p also plays a role in directing Nop1p to the nucleolus (36) . In yeast, Nop5p functional activity appears to be influenced by carboxylterminal KKX repeats (36, 38) characteristic of several nucleolar proteins, including Cbf5p (39) and Dbp3p (40) , that have also been implicated in rRNA synthesis. Removal of these repeats from Nop5p has no effect on growth at 25 or 30°C, but results in substantially reduced growth at 37°C (36) . SAN5, although highly charged at its carboxyl terminus, has only two KKX motifs. Similar to the Nop5p KKX domain deletion mutants, the San5-rescued nop5 null yeast strain grew at ambient temperature, but demonstrated poor growth at 37°C. Since our data suggest that San5 is a functional orthologue of yeast NOP5, we propose that in future studies, San5 be referred to as murine Nop5.
Growth factor receptors have evolved to transduce extracellular signals into nuclear events, ultimately resulting in activation or repression of a specific complement of genes. In yeast, adverse growth conditions result in arrested transcription of genes encoding ribosomal proteins (29) . Moreover, Wu et al. (36) have elegantly demonstrated that yeast deficient in Nop5p undergo growth arrest due to defects in early pre-rRNA processing events necessary for ribosome assembly. Similarly, in higher eukaryotes, mitogens must increase translational activity to promote effective cell division, implying a need for increased levels of ribosomal proteins (41) . Since SAN5 compensated for loss of Nop5p function, the correlation between growth factor induction of San5 and the ability of that growth factor to induce cellular proliferation is especially intriguing. This observation, coupled with the robust expression of San5 during G 1 , suggests that modulation of San5 may provide a context through which cells interpret external proliferative signals. It is tempting to speculate that altering San5 activity may present a unique approach for arresting aberrant cell growth associated with many disease processes.
